CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 75 filers reported holding CUE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $98,000 | -56.6% | 20,000 | 0.0% | 0.02% | -55.9% |
Q4 2021 | $226,000 | -22.3% | 20,000 | 0.0% | 0.03% | -55.3% |
Q3 2021 | $291,000 | +24.9% | 20,000 | 0.0% | 0.08% | +46.2% |
Q2 2021 | $233,000 | -4.5% | 20,000 | 0.0% | 0.05% | -5.5% |
Q1 2021 | $244,000 | -2.4% | 20,000 | 0.0% | 0.06% | -9.8% |
Q4 2020 | $250,000 | -16.9% | 20,000 | 0.0% | 0.06% | -26.5% |
Q3 2020 | $301,000 | – | 20,000 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 1,510,282 | $7,370,000 | 4.76% |
SANDERS MORRIS HARRIS LLC | 873,021 | $4,261,000 | 0.83% |
P.A.W. CAPITAL CORP | 150,000 | $732,000 | 0.76% |
Nantahala Capital Management | 2,244,359 | $10,952,000 | 0.48% |
Bleichroeder LP | 552,000 | $2,694,000 | 0.48% |
APOGEM CAPITAL LLC | 111,259 | $543,000 | 0.37% |
Slate Path Capital LP | 1,483,619 | $7,240,000 | 0.37% |
Robertson Stephens Wealth Management, LLC | 478,500 | $2,335,000 | 0.20% |
CARLSON CAPITAL L P | 405,000 | $1,976,000 | 0.14% |
Bridgefront Capital, LLC | 19,968 | $97,000 | 0.12% |